Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 mai 2024 08h00 HE | Source: Optimi Health Corp.

Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules

Optimi Health preparing to export 160 doses of MDMA and psilocybin under Australia’s Authorized Prescriber Scheme.
01 mars 2023 07h30 HE | Source: Optimi Health Corp.

Optimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution Agreement

Highlights: Signed Purchase Orders with Mind Medicine Australia to ensure that patients with treatment resistant post-traumatic stress disorder (PTSD) have access to medical grade GMP MDMA (using...
06 févr. 2023 08h30 HE | Source: Optimi Health Corp.

Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL

The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi’s scalable, proprietary production method. Optimi is also manufacturing MDMA under...